Related Experiment Video
Updated: Oct 16, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Challenges in Optimizing Lipid Management in Women.
Kellsey A Peterson1, Gurleen Kaur1, Eugenia Gianos2,3
1Division of Cardiology, Department of Medicine, Albany Medical College and Albany Medical Center, 47 New Scotland Ave, Albany, NY, 12208, USA.
Women experience worse dyslipidemia control than men due to underestimation of cardiovascular disease risk, lower medication use, and higher statin intolerance. Addressing these challenges is crucial for improving lipid management in women.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Physiologic differences exist in lipid metabolism between men and women.
- Current dyslipidemia management guidelines recommend similar pharmacologic strategies for both sexes.
- Despite guideline parity, women exhibit poorer dyslipidemia control compared to men.
Purpose of the Study:
- To review the efficacy of current lipid-lowering therapies in women versus men.
- To discuss challenges in lipid management specifically for women.
- To explore potential strategies to overcome these obstacles in female patients.
Main Methods:
- Review of contemporary lipid-lowering therapies.
- Analysis of studies comparing dyslipidemia control in men and women.
- Examination of factors contributing to suboptimal lipid management in women.
Main Results:
- Women face challenges including underestimation of cardiovascular risk, reduced prescription and use of lipid-lowering drugs, and increased statin intolerance.
- These factors contribute to lower achievement of lipid targets in women.
- Heart disease is the leading cause of mortality in women, often diagnosed later than in men.
Conclusions:
- Despite similar treatment guidelines, women have worse dyslipidemia control.
- Unique risk factors in women, such as pregnancy-related disorders, necessitate tailored risk stratification.
- Addressing specific challenges in women is essential for effective lipid management and cardiovascular risk reduction.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

